Pharmacological treatment of severe, therapy-resistant asthma in children: what can we learn from where? PSACI (Problematic Severe Asthma in Childhood Initiative) group

Abstract

There is a lack of high-quality evidence on what treatment should be used in children with properly characterised severe, therapy-resistant asthma. Data have to be largely extrapolated from trials in children with mild asthma, and adults with severe asthma